Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.81 |
| ▸ | RAB9A | P51151 | 1/20 | 0.64 |
| ▸ | JAK2 | O60674 | 2/20 | 0.63 |
| ▸ | JAK1 | P23458 | 2/20 | 0.63 |
| ▸ | MEN1 | O00255 | 5/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | MITF | O75030 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4925703 | 0.82 | NPC1 (0.58) | NPC1RAB9AJAK2JAK1MEN1 | |
| SCHEMBL6429865 | 0.81 | NPC1 (0.55) | NPC1RAB9AMEN1KMT2AALDH1A1 | |
| SCHEMBL13995836 | 0.80 | NPC1 (0.68) | NPC1RAB9AJAK2JAK1MEN1 | |
| SCHEMBL1663908 | 0.80 | NPC1 (0.64) | NPC1RAB9AJAK2JAK1MEN1 | |
| SCHEMBL24040867 | 0.79 | NPC1 (0.63) | NPC1RAB9AJAK2JAK1MEN1 | |
| SCHEMBL30444401 | 0.77 | NPC1 (0.57) | NPC1RAB9AJAK2JAK1MEN1 | |
| SCHEMBL3328193 | 0.77 | NPC1 (0.57) | NPC1RAB9AJAK2JAK1MEN1 | |
| SCHEMBL4440201 | 0.77 | NPC1 (0.60) | NPC1JAK2JAK1MEN1KMT2A | |
| SCHEMBL17318545 | 0.76 | RAB9A (0.66) | NPC1RAB9AJAK2MEN1KMT2A | |
| SCHEMBL16355148 | 0.75 | KMT2A (0.79) | NPC1RAB9AJAK2JAK1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100286149-A1 | NOVEL BENZAMIDE DERIVATIVES USEFUL AS POTASSIUM CHANNEL MODULATORS | NEUROSEARCH A/S (DK) | 2010-11-11 | — | — | US | disclosed |
| EP-2212303-A1 | NOVEL BENZAMIDE DERIVATIVES USEFUL AS POTASSIUM CHANNEL MODULATORS | NeuroSearch AS (DK) | 2010-08-04 | — | — | EP | disclosed |
| WO-2009068509-A1 | NOVEL BENZAMIDE DERIVATIVES USEFUL AS POTASSIUM CHANNEL MODULATORS | NEUROSEARCH A/S (DK) | 2009-06-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100286149-A1 | NOVEL BENZAMIDE DERIVATIVES USEFUL AS POTASSIUM CHANNEL MODULATORS | KCNA2, KCNJ2, KCNB2 | NPC1 1201/4885RAB9A 1720/4885JAK2 4256/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.